Is Deprescription of Ezetimibe Safe in Familial Hypercholesterolemia Patients Taking Evolocumab?Novel Teaching Points
We evaluated whether low-density lipoprotein cholesterol (LDL-C) levels in familial hypercholesterolemia patients on triple lipid-lowering therapy would remain below intensification threshold values after withdrawal of ezetimibe. We included 13 heterozygous familial hypercholesterolemia patients wit...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2022-04-01
|
| Serie: | CJC Open |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2589790X21003541 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|